Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling

Journal of the National Cancer Institute

Volumn 94, Issue 11, 2002, Pages 819-825

  He, Yulong ^a   Kozaki, Ken Ichi ^b   Karpanen, Terhi ^a   Koshikawa, Katsumi ^b   Yla Herttuala, Seppo ^c   Takahashi, Takashi ^b   Alitalo, Kari ^a,d  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; IMMUNOGLOBULIN; UNCLASSIFIED DRUG; VASCULOTROPIN C; VASCULOTROPIN RECEPTOR 3; VASCULOTROPIN RECEPTOR 3 IMMUNOGLOBULIN;

ANGIOGENESIS; ARTICLE; CANCER CELL CULTURE; CONFIDENCE INTERVAL; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; LUNG CANCER; LYMPH NODE METASTASIS; LYMPHANGIOMA; METASTASIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; TUMOR XENOGRAFT; VIRAL GENE DELIVERY SYSTEM;

EID: 0037024472     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/94.11.819     Document Type: Article

References (37)

1. The lymph node as a bridgehead in the metastatic dissemination of tumors
2. Lymphangiogenesis and tumor metastasis: Myth or reality?
3. The biology of vascular endothelial growth factor
4. Regulation of angiogenesis via vascular endothelial growth factor receptors
5. Angiogenesis in cancer and other diseases
6. Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis
7. Vascular endothelial growth factor-related protein: A ligand and specific activator of the tyrosine kinase receptor Flt4
8. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases
9. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)
10. VEGF and VEGF-C: Specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane
11. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice
12. Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice
13. Vascular endothelial growth factor C induces angiogenesis in vivo
14. Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia
15. c-fos-induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro
16. Cardiovascular failure in mouse embryos deficient in VEGF receptor-3
17. Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis
18. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development
19. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development
20. Absence of functional lymphatics within a murine sarcoma: A molecular and functional evaluation
21. Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors
22. VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer
23. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis
24. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis
25. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics
26. Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth
27. Establishment and characterization of a human lung cancer cell line NCI-H460-LNM35 with consistent lymphogenous metastasis via both subcutaneous and orthotopic propagation
28. Multi-faceted analyses of a highly metastatic human lung cancer cell line NCI-H460-LNM35 suggest mimicry of inflammatory cells in metastasis
29. Apoptosis in toremifene-induced growth inhibition of human breast cancer cells in vivo and in vitro
30. Adenovirus-mediated gene transfer to lower limb artery of patients with chronic critical leg ischemia
31. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3
32. Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium
33. Proteolytic processing regulates receptor specificity and activity of VEGF-C
34. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan
35. Lack of lymphangiogenesis in human primary cutaneous melanoma. Consequences for the mechanism of lymphatic dissemination
36. Involvement of vascular endothelial growth factor receptor-3 in maintenance of integrity of endothelial cell lining during tumor angiogenesis
37. Two independent mechanisms essential for tumor angiogenesis: Inhibition of human melanoma xenograft growth by interfering with either the vascular endothelial growth factor receptor pathway or the Tie-2 pathway